Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7291)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2014 (publication date) through Dec 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim HC, Suk KT, Kim DJ, Yoon JH, Kim YS, Baik GH, Kim JB, Kim CH, Sung H, Choi JY, Han KH, Park SH. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. World J Gastroenterol 2014; 20(3): 745-754 [PMID: 24574748 DOI: 10.3748/wjg.v20.i3.745] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i3/745.htm |
| Number | Citing Articles |
| 1 |
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10): 5663 doi: 10.1007/s00330-020-06931-5
|
| 2 |
Zhong-Guo Zhou, Xing-Rong Zheng, Qian Zhou, Ming Shi, Yao-Jun Zhang, Rong-Ping Guo, Yun-Fei Yuan, Min-Shan Chen, Xiao-Jun Lin, Xiang-Ming Lao, Sheng-Ping Li. Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization. Chinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0017-7
|
| 3 |
Rong‐xin Chen, Yu‐hong Gan, Ning‐lin Ge, Yi Chen, Hui Ma, Yan Wang, Bo‐heng Zhang, Yan‐hong Wang, Sheng‐long Ye, Jian‐feng Luo, Zheng‐gang Ren. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Journal of Gastroenterology and Hepatology 2016; 31(2): 442 doi: 10.1111/jgh.13077
|
| 4 |
Kenji KUTARA, Toshiaki KONNO, Hirotaka KONDO, Hinako YAMAZOE, Satoru MATSUNAGA. Triple-phase helical computed tomography of an arterio-hepatic venous shunt in a hepatic tumor in a dog. Journal of Veterinary Medical Science 2017; 79(12): 1947 doi: 10.1292/jvms.17-0373
|
| 5 |
Yang Jun Kang, Byung Chan Lee, Jae Kyu Kim, Nam Yeol Yim, Hyoung Ook Kim, Soo Buem Cho, Yong Yeon Jeong. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2020; 43(1): 55 doi: 10.1007/s00270-019-02349-9
|
| 6 |
Mohammed Bermo, Manuela C. Matesan, Malak Itani, Fatemeh Behnia, Hubert J. Vesselle. Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns. Abdominal Radiology 2018; 43(11): 3001 doi: 10.1007/s00261-018-1602-4
|
| 7 |
Samuel R. Falkson, Hriday P. Bhambhvani, Melanie Hayden Gephart. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience. World Neurosurgery 2020; 140: e27 doi: 10.1016/j.wneu.2020.03.189
|
| 8 |
Jonathan Abdelmalak, Simone I. Strasser, Natalie L. Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J. Thompson, Jessica Howell, Dhivya Pandiaraja, Steven Bollipo, Suresh Sharma, Merlyn Joseph, Rohit Sawhney, Amanda Nicoll, Nicholas Batt, Myo J. Tang, Stephen Riordan, Nicholas Hannah, James Haridy, Siddharth Sood, Eileen Lam, Elysia Greenhill, John Lubel, William Kemp, Ammar Majeed, John Zalcberg, Stuart K. Roberts. Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study. Cancers 2024; 16(17): 3010 doi: 10.3390/cancers16173010
|
| 9 |
Xihai Wang, Hongyuan Liang, Zaiming Lu. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation. Minimally Invasive Therapy & Allied Technologies 2020; 29(6): 344 doi: 10.1080/13645706.2019.1649286
|
| 10 |
Natsuhiko Saito, Toshihiro Tanaka, Hideyuki Nishiohuku, Takeshi Sato, Tetsuya Masada, Takeshi Matsumoto, Hiroshi Anai, Hiroshi Sakaguchi, Satoru Sueyoshi, Nagaaki Marugami, Kimihiko Kichikawa. Transarterial‐ chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver function. Hepatology Research 2020; 50(10): 1176 doi: 10.1111/hepr.13550
|
| 11 |
Huan Tong, Bo Wei, Shuang Chen, Yong-Mei Xie, Ming-Guang Zhang, Lin-Hao Zhang, Zhi-Yin Huang, Cheng-Wei Tang. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study. Oncotarget 2017; 8(29): 48303 doi: 10.18632/oncotarget.15684
|
| 12 |
Maureen P. Kohi. Gender-Related Differences in Hepatocellular Carcinoma: Does Sex Matter?. Journal of Vascular and Interventional Radiology 2016; 27(9): 1338 doi: 10.1016/j.jvir.2016.06.035
|
| 13 |
Benzion Amoyav, Allan I. Bloom, Yoel Goldstein, Rafael Miller, Mariana Sharam, Arnon Fluksman, Ofra Benny. Drug‐Eluting Porous Embolic Microspheres for Trans‐Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer. Advanced Healthcare Materials 2023; 12(30) doi: 10.1002/adhm.202301548
|
| 14 |
Stuart K. Roberts, Alessia Gazzola, John Lubel, Paul Gow, Sally Bell, Amanda Nicoll, Anouk Dev, Michael A. Fink, Siddharth Sood, Virginia Knight, Thai Hong, Eldho Paul, Gauri Mishra, Ammar Majeed, William Kemp. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival. Scandinavian Journal of Gastroenterology 2018; 53(10-11): 1368 doi: 10.1080/00365521.2018.1517277
|
| 15 |
Aline Mähringer-Kunz, Arndt Weinmann, Irene Schmidtmann, Sandra Koch, Sebastian Schotten, Daniel Pinto dos Santos, Michael Bernhard Pitton, Christoph Dueber, Peter Robert Galle, Roman Kloeckner. Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4407-5
|
| 16 |
Zhe Guo, Yuan Zhong, Bo Hu, Jing-Hang Jiang, Le-Qun Li, Bang-De Xiang. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria. Medicine 2017; 96(51): e8933 doi: 10.1097/MD.0000000000008933
|
| 17 |
Rongxin Chen, Yuhong Gan, Ninglin Ge, Yi Chen, Yan Wang, Boheng Zhang, Yanhong Wang, Shenglong Ye, Zhenggang Ren. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. Journal of Vascular and Interventional Radiology 2016; 27(12): 1829 doi: 10.1016/j.jvir.2016.06.010
|